[Alagille Syndrome]

Area of Science:

• Genetics
• Pediatrics
• Internal Medicine

Background:

• Alagille syndrome is a rare autosomal dominant disorder with significant intrafamilial variability.
• Physician awareness is low, leading to complex patient management involving multiple medical specialties.
• Key features include neonatal jaundice, chronic cholestasis, and various malformations.

Purpose of the Study:

• To summarize the current understanding of Alagille syndrome.
• To highlight the clinical manifestations and molecular basis.
• To underscore the need for targeted therapeutic strategies.

Main Methods:

• Review of existing literature on Alagille syndrome.
• Analysis of clinical and genetic data.
• Synthesis of information regarding Notch pathway mutations.

Main Results:

• Alagille syndrome frequently manifests with neonatal jaundice, chronic cholestasis, cardiac, ocular, and skeletal issues, alongside distinct facial features.
• Mutations in genes regulating the Notch pathway are the established molecular cause.
• Significant variability in presentation exists even within families.

Conclusions:

• The molecular underpinnings of Alagille syndrome are well-defined, primarily involving the Notch pathway.
• Despite a clear genetic basis, there are currently no specific targeted therapies available for Alagille syndrome.
• Multidisciplinary care is essential for managing the diverse clinical manifestations.